An affiliate of Peak Rock Capital has acquired Asembia, a provider of technology-enabled commercialization solutions for the specialty pharmaceutical sector. Founded in 2005 and headquartered in Florham Park, New Jersey, Asembia serves pharmaceutical manufacturers, pharmacies, patients, and prescribers.

Peak Rock Capital, established in 2012 and based in Austin, Texas, is a middle-market private equity firm with a broad investment focus. The firm actively targets companies within the healthcare industry, as well as select other sectors, operating across North America and Europe. Peak Rock typically invests between $30 million and $500 million in companies possessing enterprise values ranging from $50 million to $1.5 billion.

This strategic acquisition by Peak Rock Capital is expected to enhance Asembia's capabilities and market reach. The financial terms of the transaction have not been publicly disclosed. The deal underscores the ongoing consolidation and investment activity within the healthcare and life sciences private equity landscape, with firms like Peak Rock actively seeking opportunities to deploy capital in promising segments of the market. This move by Peak Rock highlights their commitment to expanding their presence in the healthcare sector through targeted acquisitions of companies with strong market positions and growth potential.